RecallDepth
Class II Terminated

Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL Single Dose Vials (NDC 0641-6043-01), 25 vials/shelf-pack (NDC 0641-6043-25), For IM Use Only, Rx only, Manufactured by: WEST-WARD Eatontown, NJ 07724 USA.

Company
Hikma Pharmaceuticals Usa Inc.
Recall Initiated
December 17, 2019
Posted
January 22, 2020
Recall Number
D-0658-2020
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
25,817 shelf packs/25 vials per pack
Firm Location
Cherry Hill, NJ, United States

Reason for Recall

Presence of Particulate Matter: particles identified as polydimethylsiloxane (PDMS)

Distribution

Nationwide within the United States

Lot / Code Info

038368, Exp. Mar 2020; 058314, Exp. May 2020; 078305, 078307, Exp. July 2020; 118362 Exp. Nov 2020

More recalls by Hikma Pharmaceuticals Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls